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Hybrid lesions encompass the occurrence of different entities in one lesion. A 67-year-old woman was referred to 
the Oral and Maxillofacial Surgery Service for treatment of mandibular Central Giant Cell Lesion (CGCL) pre-
viously diagnosed. Intraoral examination revealed edentulism and a painless swelling extending from the alveolar 
ridge to the buccal vestibule with hard consistency covered by normal mucosae, with unknown duration. Panora-
mic radiograph revealed a large, multilocular and well-defined radiolucent lesion extending from the region of left 
mandibular lateral incisor teeth to right mandibular first molar with no evidence of osseous perforation. Initially, a 
treatment with intralesional injection of corticosteroids was performed. After 18 months of treatment, an increase 
in size of the osteolytic lesion was noted. An incisional biopsy was carried out and the microscopic examination re-
vealed a unicystic ameloblastoma associated to CGCL. It was performed marsupialization and later the enucleation 
of residual lesion. The follow-up remains being performed.




Hybrid lesions encompass elements of different patho-
logies in one lesion and the occurrence within the jaws 
are rarely reported (1). Among these, the mostly repor-
ted hybrid lesions are odontogenic lesions: ameloblasto-
ma and glandular odontogenic cyst, ameloblastoma and 
orthokeratinised odontogenic cyst, ameloblastoma and 
odontogenic keratocyst, and unicystic ameloblastoma 
with odontogenic keratocyst (2).
Central giant cell lesion (CGCL) is a benign lesion of 
the jaws with an unknown etiology. These lesions oc-
cur more frequently in females until third decade of life 
and are often located on the anterior region of mandi-
ble. Most cases presents as a intraoral slow growing and 
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painless swelling. The radiological features are diverse 
and may vary from small unilocular to extensive multi-
locular radiolucent areas, beside displacement of teeth 
and tooth germs, root resorption, and cortical perfora-
tion. Histopathologically, CGCL is characterized by a 
cellular connective tissue permeated by mesenchymal 
ovoid and multinucleated giant cells of various sizes 
and, occasionally, with multiple foci of hemorrhage and 
trabecular bone tissue (3).
Chuong et al. classified aggressive and non-aggressive 
lesions according to signs and symptoms and histologi-
cal features. The lesion is considered aggressive when 
several of the following features are present such as pain, 
paresthesia, root resorption, rapid growth, cortical perfo-
ration, and high recurrence rate. On the other hand, the 
non-aggressive lesion is characterized by slower growth 
and absence of cortical perforation or tooth resorption 
(4). With regard to the histopathological features, ag-
gressive CGCL has a larger fractional area occupied by 
giant cells (3).  This classification determine the treat-
ment, that can be either conservative with intralesional 
corticotherapy followed by enucleation either more radi-
cal, with surgical resection (3).
Ameloblastoma is as a benign odontogenic tumor 
with origin in odontogenic epithelial cells (5). Unicys-
tic Ameloblastoma (UA) is a variant form that mostly 
occurs in a younger age group having an odontogenic 
cyst-like behavior. UA frequently appears as a unilocu-
lar radiolucent with a history of slow growing in man-
dible (5,6). Histologically, it is characterized as a cystic 
lesion lined by an ameloblastomatous epithelial lining 
with or without luminal and/ or mural tumor growth (6), 
which determine its subclassification. Because of the re-
latively benign biologic behavior, UA has good response 
to conservative treatment. Then, enucleation with or wi-
thout a previous marsupialization is indicated with a low 
rate of recurrence (5,6).
Both UA and CGCL are uncommon diseases and their 
occurrence simultaneously with another lesion is very 
rare. Here we present a case of simultaneous occurrence 
of CGCL and UA. To the best of our knowledge, this is 
the first reported case of a simultaneous occurrence of 
these two entities. 
Case Report
A 67-year-old woman was referred to the service of 
Oral and Maxillofacial Surgery for surgical treatment 
of mandibular CGCL previously diagnosed. No altera-
tions were observed on extraoral examination. Intraoral 
examination revealed a slowly and painless expansive 
lesion in the left parasymphysis of an unknown duration. 
The patient was edentulous and the swelling extended 
from anterior mandibular region to right posterior man-
dibular region, the mandibular vestibule had a hard con-
sistency, and was covered by normal mucosae. 
Medical history of the patient revealed systemic arterial 
hypertension controlled by oral drugs. A panoramic ra-
diograph from 2015 revealed a large, multilocular, we-
ll-defined radiolucent lesion extending from the region 
of left mandibular lateral incisor to right mandibular 
first molar teeth, with no evidence of cortical perforation 
(Fig. 1a). At this moment, it was proposed a conserva-
tive treatment with intralesional injection of corticoste-
roids to decrease the size of the lesion.
Fig. 1: Panoramic radiograph (PR). (A) PR taken in 2015 
showing a large, multilocular, well-defined radiolucent 
lesion extending from the region of left mandibular lat-
eral incisor to right mandibular first molar teeth. (B) PR 
taken in 2016 indicating decreases of the lesion on right 
posterior region of mandible. (C and D) PR from 2017 and 
2018, respectively, revealing increase of osteolytic com-
ponent on anterior region of mandible, extending to the 
left side. (E) PR from 2019 shows increased radiopacity 
of the lesion, indicating bone repair.
J Clin Exp Dent. 2020;12(2):e204-8.                                                                                                                                                                                                     Hybrid ameloblastoma and CGCL 
e206
During 18 months, the patient received monthly 1 ml 
of Dexamethasone (4mg/ml) applied intralesionally. To 
reassess the response to the treatment, panoramic radio-
graphs were performed in Dec/2016 (Fig. 1b), Aug/2017 
(Fig. 1c) and Feb/2018 (Fig. 1d). In the first radiography, 
the lesion decreased, specially in the right posterior re-
gion of mandible. However, the two last exams revealed 
an increase of the osteolytic component of the lesion in 
the anterior region of mandible, extending to the left side 
and causing an expansion of cortical bone on intraoral 
clinical examination. 
An incisional biopsy of this osteolytic component was 
carried out on the left side of the lesion and the speci-
men was referred to histopathological examination. The 
hematoxylin and eosin (H&E) stained sections showed 
a combined epithelial and mesenchymal lesion. The 
first component revealed an odontogenic epithelial le-
sion predominantly cystic, but with solid areas, exhibi-
ting epithelium with palisaded basal cells with hyper-
chromatic nuclei, focal reverse polarization and upper 
layers with stellate-reticulum-like cells (Fig. 2a,c). The 
mesenchymal component revealed a lesion with high ce-
llularity, with the predominance of ovoid fibroblasts and 
disorganized collagen fibers permeated by numerous 
multinucleated giant cells of different sizes (Fig. 2b,c). 
To exclude brown tumor of hyperparathyroidism (BTH), 
Fig. 2: Photomicrographs of histological section on 200x. (A) Histological section (H&E) of a mural 
proliferation area of UA showing ameloblastomatous epithelium (arrow) exhibiting palisaded basal 
cells with hyperchromatic nuclei, focal reverse polarization and upper layers with stellate-reticu-
lum-like cells. (B) Ameloblastomatous epithelium (arrow) lining a connective tissue permeated by 
multinucleated giant cells (arrowhead) of different sizes and ovoid mesenchymal cells (H&E).  (C) 
Connective tissue wall partially lined by ameloblastomatous epithelium (arrow), presenting mural 
invasion (arrow) and focal areas of multinucleated giant cells (arrowhead) of different sizes (H&E). 
(D) Connective tissue lined by ameloblastomatous epithelium (arrow) and permeated by multinucle-
ated giant cells (arrowhead) and ovoid mesenchymal cells showing immunoreactivity for CD68. (E) 
Ameloblastomatous epithelium (arrow) showing immunoreactivity for CK19 and lining a cellular 
fibroblastic connective tissue permeated by multinucleated giant cells (arrowhead) and ovoid mesen-
chymal cells. (F) Ameloblastomatous epithelium (arrow) showing immunoreactivity for pan-CK and 
lining a cellular fibroblastic connective tissue permeated by multinucleated giant cells (arrowhead) 
and ovoid mesenchymal cells. 
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laboratory exams were run and showed normal serum le-
vels of calcium, alkaline phosphatase, and parathormo-
nes. Then, the diagnosis of ameloblastoma associated to 
CGCL was confirmed.
After that, it was performed marsupialization on cystic 
component in order to promote bone formation decrea-
sing the cystic cavity.  After three months, the who-
le lesion was removed by enucleation with peripheral 
osteotomy. Once again, the specimen was submitted to 
microscopic examination and the diagnosis of UA asso-
ciated to CGCL was confirmed. Immunohistochemistry 
against CD68 highlighted the multinucleated giant and 
the mesenchymal cells (Fig. 2d), whereas cytokeratin 
19 (CK19) and high molecular weight cytokeratin (pan-
CK) stained the odontogenic epithelium (Fig. 2e,f).
The last radiography was taken in May 2019 (Fig. 1e) 
and revealed decreasement of the lesion, indicating bone 
repair. Regular follow up has not shown recurrence after 
10 months of the surgical treatment.  
Discussion
Hybrid lesions or combined lesions have been rarely des-
cribed in the literature. CGCL was reported in association 
with central odontogenic fibroma (COF) (7), fibro-os-
seous lesions (1), and with odontogenic keratocyst (8). 
On the other hand, few cases of hybrid lesions involving 
ameloblastoma have been reported. Cousin (9) reported 
the co-occurrence of glandular odontogenic cyst associa-
ted to ameloblastoma, Gupta (2) reported the occurrence 
of odontogenic keratocyst with unicystic ameloblastoma 
and Fregnani (10) described the simultaneous occurrence 
of ameloblastoma and orthokeratinized cyst.
Here we presented a case of CGCL associated with UA. 
Kawakami (11) previously described the presence of 
giant cells adjacent to a solid ameloblastoma as a re-
active process, however in the current case other com-
ponents of CGCL was seen, as abundance of ovoid to 
spindle mesenchymal cells and hemosiderin deposition. 
Furthermore, the origin of both lesions was investigated 
through immunohistochemistry, and the ameloblastic 
epithelium was positive for CK19, as reported by Upad-
hyaya et al. (7) and the CGCL component (mesenchy-
mal and giant cells) was positive for CD68, as demons-
trated by Liu et al. (12). However, the pathogenesis of 
those lesions remains unknown. 
In cases of COF associated with CGCL three majors pa-
thogenesis hypothesis had been pointed: a) a collision 
tumor, which results from the synchronous occurrence 
of the lesions; b) COF is the primary lesion and induces 
a GCGL reaction in response to trauma or other stimu-
lus; or (c) CGCL produces growth factors, chemokines 
and cytokines that stimulates the proliferation of odon-
togenic cells, resulting on the COF (7). 
Since our case is the first one described in the literatu-
re, there are no previous studies about its pathogenesis. 
Based on theories described above, clinical history and 
radiographic examinations, this case seems to be a real 
collision tumor for two majors reasons: first, the primary 
incisional biopsy revealed just the CGCL, without sig-
ns of odontogenic lesion, leading to the conclusion that 
CGCL was the predominant lesion in the beginning. The 
second point is the fact that the patient responded well 
to the treatment with intralesional corticosteroids, a spe-
cific treatment against CGCL, for 18 months. Therefore 
the patient probably had two separated lesions that co-
llided when the UA growed up and reached the CGCL. 
In addition, we forwent the theory that the CGCL would 
stimulate the proliferation of odontogenic cells, because 
if this was a typical phenomenon, we believe that the 
presence of odontogenic tumors associated with CGCL 
would be commonly seen.
Currently, there are few cases of collision tumors publi-
shed, probably because these lesions are unnoticed and/
or diagnosed according to one of the prominent micros-
copic features. This limited number of cases lead to be 
difficult to predict their biologic behavior (13).
In the presented case, the initial diagnosis was CGCL. 
Due to lesion size and patient’s age, initially a conserva-
tive treatment was carried out. The most common intra-
lesional drug used for CGCL in the cases reported in the 
literature is triamcinolone acetonide (14), but dexame-
thasone also is applied. Body et al. was the first to report 
the use of corticosteroids in the treatment of CGCL. In 
their case it was administered systemic dexamethaso-
ne, which leads to lesion reduction but also to systemic 
complications (15). In 1994, Terry and Jacoway first re-
ported the treatment of CGCL with intralesional corti-
costeroid injections and recently a meta-analytic study 
demonstrated a good response of aggressive and non-ag-
gressive CGCL with this therapeutic modality (4).
Due to the good results previously described with the 
use of dexamethasone, this modality of treatment was 
applied in the current patient. With the last biopsy revea-
ling the presence of a UA component, surgical approach 
was planned. The marsupialization was performed fo-
llowed by enucleation of the residual lesion with peri-
pheral osteotomy to prevent recurrence.
Some studies have reported a higher risk of recurrence 
for hybrid lesions or collision tumors with CGCL com-
ponent, recommending a long-term follow up and careful 
management (13). After 10 months of follow-up of the 
current case, no sign of recurrence has been observed. 
To the best of our knowledge, this is the first case of 
UA and CGCL occurring simultaneously reported in 
English literature. Despite the clinical, radiological and 
histopathological features, the exact timing of onset of 
the lesions, concomitantly or independently, remains un-
certain. It is necessary further studies with long-term fo-
llow-up information to understand the pathogenesis and 
biologic behavior of hybrid lesions and collision tumors.
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